Home Mf Research Aditya Birla Sun Life Pharma Healthcare Fund Regular Plan Growth

Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth

-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • SI
Fund info
NAV (as on 2025-10-17)
31.25 0.16%
AUM (Fund Size)
34
Expense Ratio
2.33%
Exit load
For redemption/switch-out of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil
Risk
Very High
AMC
Aditya Birla Sun Life Mutual Fund
View AMC Details

SIP Returns

Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2025-10-10 ₹1,000.00 ₹1,000.64
0.06 %
Two Week 2025-10-03 ₹1,000.00 ₹1,021.91
2.19 %
One Month 2025-09-17 ₹1,000.00 ₹995.22
-0.48 %
Three Months 2025-07-21 ₹3,000.00 ₹2,972.51
-0.92 %
Six Months 2025-04-21 ₹6,000.00 ₹6,112.71
1.88 %
One Year 2024-10-17 ₹12,000.00 ₹12,426.49
3.55 %
Three Year 2022-10-18 ₹36,000.00 ₹47,975.08
33.26 %
Five Year 2020-10-19 ₹60,000.00 ₹91,180.63
51.97 %
Since Inception 2019-07-10 ₹77,000.00 ₹135,823.10
76.39 %

Return Calculator

SIP Amount
1M
6M
1Y
3Y
5Y
Investment
₹0
Maturity Value
₹0
Abs. Returns
0
Current CAGR
0

Portfolio

Allocation of Equity and Debt Asset Classes.

Equity 83%
Debt 2%
Others 0%

Sectors Holding in Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth

Pharmaceuticals & Biotechnology
67%
Healthcare Services
15%
Insurance
1%
Chemicals & Petrochemicals
0%
Other
2%

Companies Holding in Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth

Sun Pharmaceutical Industries Limited
12.08%
Cipla Limited
7.69%
Apollo Hospitals Enterprise Limited
7.18%
Abbott India Limited
6.09%
Torrent Pharmaceuticals Limited
5.47%
Lupin Limited
4.72%
Fortis Healthcare Limited
4.58%
Ajanta Pharmaceuticals Limited
3.99%
IPCA Laboratories Limited
3.85%
Aurobindo Pharma Limited
3.82%
Alkem Laboratories Limited
3.12%
Mankind Pharma Ltd
3.05%
ALEMBIC PHARMACEUTICALS LIMITED
3.00%
Emcure Pharmaceuticals Ltd
2.90%
J.B. Chemicals & Pharmaceuticals Limited
2.90%
GlaxoSmithKline Pharmaceuticals Limited
2.83%
SAI Life Sciences Ltd
2.37%
Jupiter Life Line Hospitals Ltd
2.36%
Divi's Laboratories Limited
2.11%
Medi Assist Healthcare Services Ltd
1.59%
Dr. Reddys Laboratories Limited
1.52%
Sanofi India Limited
1.47%
METROPOLIS HEALTHCARE LIMITED
1.39%
Procter & Gamble Health Limited
1.34%
Suraksha Diagnostic Ltd
1.32%
Akums Drugs & Pharmaceuticals Ltd
1.21%
SANOFI CONSUMER HEALTHCARE
1.21%
Max Healthcare Institute Limited
0.97%
Vijaya Diagnostic Centre Limited
0.92%
Vinati Organics Limited
0.88%
Clearing Corporation Of India Limited
2.17%
Net Receivables / (Payables)
-0.10%

Risk Ratios

Std. Deviation 15.99
Beta 0.96
Sharpe Ratio 0.97
Lock In Period N/A
Residual Maturity N/A

Standard Deviation:

Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.

Beta:

Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.

Sharpe Ratio:

The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.

Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.

Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.

Risk-O-Meter

Investors understand that their principal will be at
Very High

Scheme Details

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio Regular
2.33
Expense Ratio Direct
1.05
Lock-in Period
N/A
Fund Age
N/A
Benchmark
N/A
Fund managers
Mr. Dhaval Shah
Experience
Mr. Dhaval Joshi
Experience

Exit load

For redemption/switch-out of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil

FAQs

Is a Mutual Fund with a Lower NAV Better?
What Are the Charges in Mutual Fund Investments?
What Are the Tax Benefits of Mutual Funds?
Is It a Good Time to Invest in Mutual Funds?
What Is the Difference Between Dividend and Growth Plans?
Should I Invest in Infrastructure Funds?
What Are Sector-Specific Funds/Schemes?
What Happens If I Miss an SIP Payment?
How Can I Compare Different Mutual Funds?